MatchMiner is an open computational platform for matching patient-specific genomic profiles to precision cancer medicine clinical trials.
May 20th is International Clinical Trials Day!
In honor of this occasion, we are pleased to announce that MatchMiner from Dana-Farber Cancer Institute is the winner of the HBS/Kraft Precision Trials Challenge. Read about MatchMiner’s open platform for matching patients to clinical trials below.
The two runners up are Clinical Trial Cooperatives (or No Patient Left Behind), submitted by Merrimack Pharmaceuticals and Using Patient Specific Cancer Mutanome (or iCare for Cancer) from the University of FL.
Congratulations to all who participated!